NovaPharmaNews
THE PULSE OF GLOBAL PHARMA REGULATION
 
EUROPE · EMA INTELLIGENCE
EU edition · 2026-01
EU pharma briefing — 2026-01
 
EMA's 2026 Programming Document

REGULATORY · EMA

EMA's 2026 Programming Document

The EMA has outlined its strategic focus for 2026-2028, emphasizing preparation for new pharmaceutical rules and enhancing support for rapid authorizations.

 
NE

REGULATORY · EMA

New EU GMP Guidelines

The updated EU GMP guidelines for Part I and Part II are set to enhance quality assurance in manufacturing, aligning with international standards.

 
MO

REGULATORY · EMA

Monitoring of Critical Medicines

The EMA will oversee critical medicines through a dedicated group to mitigate shortages and ensure consistent supply across the EU.

 
Key changes in EU pharmaceutical legislation for 2026

ARTICLE

Key changes in EU pharmaceutical legislation for 2026

The European Union has enacted significant reforms in pharmaceutical legislation effective January 2026. These changes include a reduction in exclusivity periods, now contingent on genuine market presence across all Member States. Notably...

 
Quality Control for Packaging Lines

MANUFACTURING · EDQM

Quality Control for Packaging Lines

The EDQM has proposed that manufacturers implement monitoring systems for packaging lines to ensure compliance with quality standards for hospital-scannable barcodes.

 
RC

MANUFACTURING

Regulatory Compliance for Parallel Traders

New regulations require parallel traders to include both originator batch numbers and repackaging codes in EU repositories to enhance traceability.

 

Official sources

  1. https://www.ema.europa.eu/en/human-regulatory-overview/research-development/compliance-research-development/good-manufacturing-practice/guidance-good-manufacturing-practice-good-distribution-practice-questions-answers
  2. https://www.ema.europa.eu/en/documents/report/final-programming-document-2026-28_en.pdf
www.novapharmanews.com
Trusted by manufacturing, regulatory affairs, and quality teams across Europe.
EU · Edition 2026-01 · B2B pharma intelligence, generated and reviewed by editors.
© NovaPharmaNews. Trusted pharmaceutical intelligence covering FDA, EMA, NMPA, and PMDA regulatory developments across global markets.